is there any long term safety data at all or is it phase 2 and hope
#retatrutide 2025-07-15
Tuesday18 messages5 participantstimes are UTC
Highlights from this day
- lot_number_lou — how slow is low and slow here, four weeks a step or longer 11:15
- lot_number_lou — i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind the purity spread across lots worries me more than the… 12:25
- lot_number_lou — for the archive people insist on small steps because the side effects arrive faster than on the other two 12:29
no idea whether the heart rate settles for everyone, mine did and one log isnt data
sat at 1.7 for 6 months rather than climbing and it kept working, so i never went up
*PeptideMeter not the other one
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
update on the earlier thing the half life supports weekly dosing and thats what ive done from the start
*week 27 not week 9
smaller steps here
how slow is low and slow here, four weeks a step or longer
🧪5
whats the half life like, is it weekly the same way
my resting heart rate is up about 4 bpm, did that settle for anyone
*that should say weekly
i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind
the purity spread across lots worries me more than the molecule does
for the archive people insist on small steps because the side effects arrive faster than on the other two
✅11🧪10⚠️3
while im here appetite suppression at 2.5 was stronger than my tirzepatide experience at a comparable point
low and slow
did the phase 2 result actually come in higher than the tirzepatide numbers
settled by month three